News & Updates
Showing Endocrinology articles
Showing

Tirzepatide reduces weight in women with obesity across reproductive stages
Treatment with tirzepatide, compared with placebo, results in significant reductions in body weight, waist circumference, and waist-to-height ratio (WHtR) among women with obesity or overweight and without type 2 diabetes (T2D), regardless of reproductive stage.
Tirzepatide reduces weight in women with obesity across reproductive stages
09 May 2025
Metformin shows knee OA pain-relieving potential
Metformin, a common medication for diabetes, appears to produce a moderate reduction in knee pain and stiffness for overweight or obese individuals with symptomatic knee osteoarthritis (OA), as shown in the results of a randomized clinical trial.
Metformin shows knee OA pain-relieving potential
03 May 2025
Proteomic analysis identifies DKD progression markers in YT2D
A comprehensive analysis of circulating proteins identifies known and novel proteins associated with the progression of diabetic kidney disease (DKD) in Asians with younger-onset type 2 diabetes (YT2D; T2D onset age <40 years).
Proteomic analysis identifies DKD progression markers in YT2D
29 Apr 2025
Progestin-only contraceptives may pose NAFLD risk among women with GDM history
The use of progestin-only contraceptives may put women with a history of gestational diabetes mellitus (GDM) at risk of nonalcoholic fatty liver disease (NAFLD), as shown in a small prospective study.





